Genistein as a Potential Anticancer Agent against Ovarian Cancer

Journal of Traditional and Complementary Medicine

Volumn 2, Issue 2, 2012, Pages 96-104

  Lee, Jung Yun ^a   Kim, Hee ^a   Song, Yong Sang ^a,b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Genistein; Isoflavone; Ovarian cancer

Indexed keywords

EID: 84891355258     PISSN: None     EISSN: 22254110     Source Type: Journal    
DOI: 10.1016/S2225-4110(16)30082-7     Document Type: Article

References (71)

1. Adlercreutz, H., Markkanen, H., Watanabe, S., 1993. Plasma concentrations of phyto-oestrogens in Japanese men. Lancet 342, 1209-1210.
2. Ahmed, A.A., Goldsmith, J., Fokt, I., Le, X.F., Krzysko, K.A., Lesyng, B., Bast, R.C., Jr., Priebe, W., 2011. A genistein derivative, ITB-301, induces microtubule depolymerization and mitotic arrest in multidrug-resistant ovarian cancer. Cancer Chemotherapy and Pharmacology 68, 1033-1044.
3. Akiyama, T., Ishida, J., Nakagawa, S., Ogawara, H., Watanabe, S., Itoh, N., Shibuya, M., Fukami, Y., 1987. Genistein, a specific inhibitor of tyrosine-specific protein kinases. Journal of Biological Chemistry 262, 5592-5595.
4. Allred, C.D., Allred, K.F., Ju, Y.H., Virant, S.M., Helferich, W.G., 2001. Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in a dose-dependent manner. Cancer Research 61, 5045-5050.
5. Ames, B.N., Gold, L.S., Willett, W.C., 1995. The causes and prevention of cancer. Proceedings of the National Academy of Sciences of the United States of America 92, 5258-5265.
6. Andres, S., Abraham, K., Appel, K.E., Lampen, A., 2011. Risks and benefits of dietary isoflavones for cancer. Critical Reviews in Toxicology 41, 463-506.
7. Bandera, E.V., King, M., Chandran, U., Paddock, L.E., Rodriguez-Rodriguez, L., Olson, S.H., 2011. Phytoestrogen consumption from foods and supplements and epithelial ovarian cancer risk: a population-based case control study. BMC Women's Health 11, 40.
8. Banerjee, S., Li, Y., Wang, Z., Sarkar, F.H., 2008. Multi-targeted therapy of cancer by genistein. Cancer Letters 269, 226-242.
9. Brandenberger, A.W., Tee, M.K., Jaffe, R.B., 1998. Estrogen receptor alpha (ER-alpha) and beta (ER-beta) mRNAs in normal ovary, ovarian serous cystadenocarcinoma and ovarian cancer cell lines: down-regulation of ER-beta in neoplastic tissues. Journal of Clinical Endocrinology and Metabolism 83, 1025-1028.
10. Brunet, A., Bonni, A., Zigmond, M.J., Lin, M.Z., Juo, P., Hu, L.S., Anderson, M.J., Arden, K.C., Blenis, J., Greenberg, M.E., 1999. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96, 857-868.
11. Cardone, M.H., Roy, N., Stennicke, H.R., Salvesen, G.S., Franke, T.F., Stanbridge, E., Frisch, S., Reed, J.C., 1998. Regulation of cell death protease caspase-9 by phosphorylation. Science 282, 1318-1321.
12. Carmeliet, P., Jain, R.K., 2000. Angiogenesis in cancer and other diseases. Nature 407, 249-257.
13. Chang, E.T., Lee, V.S., Canchola, A.J., Clarke, C.A., Purdie, D.M., Reynolds, P., Anton-Culver, H., Bernstein, L., Deapen, D., Peel, D., Pinder, R., Ross, R.K., Stram, D.O., West, D.W., Wright, W., Ziogas, A., Horn-Ross, P.L., 2007. Diet and risk of ovarian cancer in the California Teachers Study cohort. American Journal of Epidemiology 165, 802-813.
14. Chen, X., Anderson, J.J., 2001. Isoflavones inhibit proliferation of ovarian cancer cells in vitro via an estrogen receptor-dependent pathway. Nutrition and Cancer 41, 165-171.
15. Choi, E.J., Kim, T., Lee, M.S., 2007. Pro-apoptotic effect and cytotoxicity of genistein and genistin in human ovarian cancer SKOV-3 cells. Life Science 80, 1403-1408.
16. Chu, S., Mamers, P., Burger, H.G., Fuller, P.J., 2000. Estrogen receptor isoform gene expression in ovarian stromal and epithelial tumors. Journal of Clinical Endocrinology and Metabolism 85, 1200-1205.
17. Couse, J.F., Lindzey, J., Grandien, K., Gustafsson, J.A., Korach, K.S., 1997. Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse. Endocrinology 138, 4613-4621.
18. Davis, J.N., Kucuk, O., Djuric, Z., Sarkar, F.H., 2001. Soy isoflavone supplementation in healthy men prevents NF-kappa B activation by TNF-alpha in blood lymphocytes. Free Radical Biology and Medicine 30, 1293-1302.
19. De Wilde, A., Maria Rassi, C., Cournot, G., Colin, C., Lacroix, H.C., Chaumaz, G., Coxam, V., Bennetau-Pelissero, C., Pointillart, A., Lieberherr, M., 2007. Dietary isoflavones act on bone marrow osteoprogenitor cells and stimulate ovary development before influencing bone mass in pre-pubertal piglets. Journal of Physiological Sciences 212, 51-59.
20. Diel, P., Hertrampf, T., Seibel, J., Laudenbach-Leschowsky, U., Kolba, S., Vollmer, G., 2006. Combinatorial effects of the phytoestrogen genistein and of estradiol in uterus and liver of female Wistar rats. Journal of Steroid Biochemistry and Molecular Biology 102, 60-70.
21. Dorward, A.M., Shultz, K.L., Beamer, W.G., 2007. LH analog and dietary isoflavones support ovarian granulosa cell tumor development in a spontaneous mouse model. Endocrine-Related Cancer 14, 369-379.
22. Dreher, D., Junod, A.F., 1996. Role of oxygen free radicals in cancer development. European Journal of Cancer Prevention 32, 30-38.
23. Elstrom, R.L., Bauer, D.E., Buzzai, M., Karnauskas, R., Harris, M.H., Plas, D.R., Zhuang, H., Cinalli, R.M., Alavi, A., Rudin, C.M., Thompson, C.B., 2004. Akt stimulates aerobic glycolysis in cancer cells. Cancer Research 64, 3892-3899.
24. Fathalla, M.F., 1971. Incessant ovulation-a factor in ovarian neoplasia? Lancet 2, 163.
25. Fotsis, T., Pepper, M., Adlercreutz, H., Hase, T., Montesano, R., Schweigerer, L., 1995. Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis. Journal of Nutrition 125, 790-797.
26. Gercel-Taylor, C., Feitelson, A.K., Taylor, D.D., 2004. Inhibitory effect of genistein and daidzein on ovarian cancer cell growth. Anticancer Research 24, 795-800.
27. Gossner, G., Choi, M., Tan, L., Fogoros, S., Griffith, K.A., Kuenker, M., Liu, J.R., 2007. Genistein-induced apoptosis and autophagocytosis in ovarian cancer cells. Gynecologic Oncology 105, 23-30.
28. Harris, D.M., Besselink, E., Henning, S.M., Go, V.L., Heber, D., 2005. Phytoestrogens induce differential estrogen receptor alpha-or Betamediated responses in transfected breast cancer cells. Experimental Biology and Medicine (Maywood) 230, 558-568.
29. Hedelin, M., Lof, M., Andersson, T.M., Adlercreutz, H., Weiderpass, E., 2011. Dietary phytoestrogens and the risk of ovarian cancer in the women's lifestyle and health cohort study. Cancer Epidemiology, Biomarkers & Prevention 20, 308-317.
30. Hernandez-Montes, E., Pollard, S.E., Vauzour, D., Jofre-Montseny, L., Rota, C., Rimbach, G., Weinberg, P.D., Spencer, J.P., 2006. Activation of glutathione peroxidase via Nrf1 mediates genistein's protection against oxidative endothelial cell injury. Biochemical and Biophysical Research Communications 346, 851-859.
31. Kasiske, B.L., O'donnell, M.P., Lee, H., Kim, Y., Keane, W.F., 1991. Impact of dietary fatty acid supplementation on renal injury in obese Zucker rats. Kidney International 39, 1125-1134.
32. Kim, M.K., Kim, K., Han, J.Y., Lim, J.M., Song, Y.S., 2011. Modulation of inflammatory signaling pathways by phytochemicals in ovarian cancer. Genes and Nutrition 6, 109-115.
33. Kuiper, G.G., Lemmen, J.G., Carlsson, B., Corton, J.C., Safe, S.H., Van Der Saag, P.T., Van Der Burg, B., Gustafsson, J.A., 1998. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139, 4252-4263.
34. Kyle, E., Neckers, L., Takimoto, C., Curt, G., Bergan, R., 1997. Genistein-induced apoptosis of prostate cancer cells is preceded by a specific decrease in focal adhesion kinase activity. Molecular Pharmacology 51, 193-200.
35. Lee, H.P., Gourley, L., Duffy, S.W., Esteve, J., Lee, J., Day, N.E., 1991. Dietary effects on breast-cancer risk in Singapore. Lancet 337, 1197-1200.
36. Lee, M.M., Gomez, S.L., Chang, J.S., Wey, M., Wang, R.T., Hsing, A.W., 2003. Soy and isoflavone consumption in relation to prostate cancer risk in China. Cancer Epidemiology, Biomarkers and Prevention 12, 665-668.
37. Li, Y., Bhuiyan, M., Sarkar, F.H., 1999. Induction of apoptosis and inhibition of c-erbB-2 in MDA-MB-435 cells by genistein. International Journal of Oncology 15, 525-533.
38. Li, Y., Sarkar, F.H., 2002. Inhibition of nuclear factor kappaB activation in PC3 cells by genistein is mediated via Akt signaling pathway. Clinical Cancer Research 8, 2369-2377.
39. Lian, Z., Niwa, K., Tagami, K., Hashimoto, M., Gao, J., Yokoyama, Y., Mori, H., Tamaya, T., 2001. Preventive effects of isoflavones, genistein and daidzein, on estradiol-17beta-related endometrial carcinogenesis in mice. Japanese Journal of Cancer Research 92, 726-734.
40. Luo, H., Jiang, B.H., King, S.M., Chen, Y.C., 2008. Inhibition of cell growth and VEGF expression in ovarian cancer cells by flavonoids. Nutrition and Cancer 60, 800-809.
41. Magee, P.J., Rowland, I.R., 2004. Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer. British Journal of Nutrition 91, 513-531.
42. Mosselman, S., Polman, J., Dijkema, R., 1996. ER beta: identification and characterization of a novel human estrogen receptor. FEBS Letters 392, 49-53.
43. Myung, S.K., Ju, W., Choi, H.J., Kim, S.C., 2009. Soy intake and risk of endocrine-related gynaecological cancer: a meta-analysis. British Journal of Obstetrics and Gynaecology 116, 1697-1705.
44. Ness, R.B., Cottreau, C., 1999. Possible role of ovarian epithelial inflammation in ovarian cancer. Journal of the National Cancer Institute 91, 1459-1467.
45. Oesterreich, S., Zhang, P., Guler, R.L., Sun, X., Curran, E.M., Welshons, W.V., Osborne, C.K., Lee, A.V., 2001. Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth. Cancer Research 61, 5771-5777.
46. Ouyang, G., Yao, L., Ruan, K., Song, G., Mao, Y., Bao, S., 2009. Genistein induces G2/M cell cycle arrest and apoptosis of human ovarian cancer cells via activation of DNA damage checkpoint pathways. Cell Biology International 33, 1237-1244.
47. Ozes, O.N., Mayo, L.D., Gustin, J.A., Pfeffer, S.R., Pfeffer, L.M., Donner, D.B., 1999. NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401, 82-85.
48. Parkin, D.M., Pisani, P., Ferlay, J., 1999. Global cancer statistics. CA: A Cancer Journal of Clinicians 49, 33-64.
49. Peeters, P.H., Keinan-Boker, L., Van Der Schouw, Y.T., Grobbee, D.E., 2003. Phytoestrogens and breast cancer risk. Review of the epidemiological evidence. Breast Cancer Research and Treatment 77, 171-183.
50. Pike, A.C., Brzozowski, A.M., Hubbard, R.E., Bonn, T., Thorsell, A.G., Engstrom, O., Ljunggren, J., Gustafsson, J.A., Carlquist, M., 1999. Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO Journal 18, 4608-4618.
51. Rimoldi, G., Christoffel, J., Seidlova-Wuttke, D., Jarry, H., Wuttke, W., 2007. Effects of chronic genistein treatment in mammary gland, uterus, and vagina. Environmental Health Perspectives 115, 62-68.
52. Romashkova, J.A., Makarov, S.S., 1999. NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature 401, 86-90.
53. Rossi, M., Negri, E., Lagiou, P., Talamini, R., Dal Maso, L., Montella, M., Franceschi, S., La Vecchia, C., 2008. Flavonoids and ovarian cancer risk: A case-control study in Italy. International Journal of Cancer 123, 895-898.
54. Rucinska, A., Kirko, S., Gabryelak, T., 2007. Effect of the phytoestrogen, genistein-8-C-glucoside, on Chinese hamster ovary cells in vitro . Cell Biology International 31, 1371-1378.
55. Ruiz-Larrea, M.B., Mohan, A.R., Paganga, G., Miller, N.J., Bolwell, G.P., Rice-Evans, C.A., 1997. Antioxidant activity of phytoestrogenic isoflavones. Free Radical Research 26, 63-70.
56. Sakauchi, F., Khan, M.M., Mori, M., Kubo, T., Fujino, Y., Suzuki, S., Tokudome, S., Tamakoshi, A., 2007. Dietary habits and risk of ovarian cancer death in a large-scale cohort study (JACC study) in Japan. Nutrtion and Cancer 57, 138-145.
57. Sarkar, F.H., Li, Y., 2002. Mechanisms of cancer chemoprevention by soy isoflavone genistein. Cancer Metastasis Reviews 21, 265-280.
58. Semenza, G.L., Artemov, D., Bedi, A., Bhujwalla, Z., Chiles, K., Feldser, D., Laughner, E., Ravi, R., Simons, J., Taghavi, P., Zhong, H., 2001. 'The metabolism of tumours': 70 years later. Novartis Foundation Symposium 240, 251-260.
59. Seo, H.S., Denardo, D.G., Jacquot, Y., Laios, I., Vidal, D.S., Zambrana, C.R., Leclercq, G., Brown, P.H., 2006. Stimulatory effect of genistein and apigenin on the growth of breast cancer cells correlates with their ability to activate ER alpha. Breast Cancer Research and Treatment 99, 121-134.
60. Solomon, L.A., Ali, S., Banerjee, S., Munkarah, A.R., Morris, R.T., Sarkar, F.H., 2008. Sensitization of ovarian cancer cells to cisplatin by genistein: the role of NF-kappaB. Journal of Ovarian Research 1, 9.
61. Spinozzi, F., Pagliacci, M.C., Migliorati, G., Moraca, R., Grignani, F., Riccardi, C., Nicoletti, I., 1994. The natural tyrosine kinase inhibitor genistein produces cell cycle arrest and apoptosis in Jurkat T-leukemia cells. Leukemia Research 18, 431-439.
62. Stadel, B.V., 1975. Letter: The etiology and prevention of ovarian cancer. American Journal of Obstetrics and Gynecology 123, 772-774.
63. Strom, A., Hartman, J., Foster, J.S., Kietz, S., Wimalasena, J., Gustafsson, J.A., 2004. Estrogen receptor beta inhibits 17betaestradiol- stimulated proliferation of the breast cancer cell line T47D. Proceedings of the National Academy of Sciences of the United States of America 101, 1566-1571.
64. Tanaka, T., Kohno, H., Tanino, M., Yanaida, Y., 2002. Inhibitory effects of estrogenic compounds, 4-nonylphenol and genistein, on 7, 12-dimethylbenz[a] anthracene-induced ovarian carcinogenesis in rats. Ecotoxicology and Environmental Safety 52, 38-45.
65. Taylor, C.K., Levy, R.M., Elliott, J.C., Burnett, B.P., 2009. The effect of genistein aglycone on cancer and cancer risk: a review of in vitro , preclinical, and clinical studies. Nutrition Reviews 67, 398-415.
66. Treeck, O., Pfeiler, G., Mitter, D., Lattrich, C., Piendl, G., Ortmann, O., 2007. Estrogen receptor {beta}1 exerts antitumoral effects on SK-OV-3 ovarian cancer cells. Journal of Endocrinology 193, 421-433.
67. Trock, B.J., Hilakivi-Clarke, L., Clarke, R., 2006. Meta-analysis of soy intake and breast cancer risk. Journal of National Cancer Institute 98, 459-471.
68. Van Antwerp, D.J., Martin, S.J., Kafri, T., Green, D.R., Verma, I.M., 1996. Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science 274, 787-789.
69. Weber, G., 1977. Enzymology of cancer cells (first of two parts). New England Journal of Medicine 296, 486-492.
70. Wu, M., Lee, H., Bellas, R.E., Schauer, S.L., Arsura, M., Katz, D., Fitzgerald, M.J., Rothstein, T.L., Sherr, D.H., Sonenshein, G.E., 1996. Inhibition of NF-kappaB/Rel induces apoptosis of murine B cells. EMBO Journal 15, 4682-4690.
71. Zhang, M., Xie, X., Lee, A.H., Binns, C.W., 2004. Soy and isoflavone intake are associated with reduced risk of ovarian cancer in southeast china. Nutrition and Cancer 49, 125-130.